Special Review Decision SRD2020-01, Special Review Decision: Acephate
This document presents the final regulatory decision for the special review of acephate. To comply with this decision, the required label changes related to the aspects of concern included in RVD2020-07 must be implemented on all product labels sold by registrants no later than 24 months after the publication date of this document.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Special Review Decision SRD2020-01, Special Review Decision: AcephateHTMLEnglish publication HTML
-
Special Review Decision SRD2020-01, Special Review Decision: AcephateHTMLFrench publication HTML
Similar records